Rheacell GmbH & Co. KG   Report issue

For profit Phase 2
Founded: Heidelberg Germany (2012)

Organization Overview

First Clinical Trial
2016
NCT02742844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

RHEACELL GmbH & Co. KG